Table of Content
1. Executive Summary
2. Market Background and Classifications
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2013 to 2024
3.1: Macroeconomic Trends and Forecast
3.2: Global Esoteric Testing Market: Trends and Forecast
3.3: Global Esoteric Testing Market by Product Type
3.3.1: Infectious Diseases Testing
3.3.2: Endocrinology Testing
3.3.3: Oncology Testing
3.3.4: Immunology Testing
3.3.5: Genetic Testing
3.3.6: Toxicology Testing
3.3.7: Neurology Testing
3.3.8: Others
3.4: Global Esoteric Testing Market by Technology
3.4.1: Chemiluminescence Immunoassay (CLIA)
3.4.2: Enzyme-linked Immunosorbent Assay (ELISA)
3.4.3: Mass Spectrometry
3.4.4: Real Time – PCR
3.4.5: Flow Cytometry
3.4.6: Radioimmunoassay
3.4.7: Others
3.5: Global Esoteric Testing Market by End User
3.5.1: Independent and Reference Laboratories
3.5.2: Hospital Laboratories
4. Market Trends and Forecast Analysis by Region
4.1: Global Esoteric Testing Market by Region
4.2: North American Esoteric Testing Market
4.2.1: Market by Product Type: Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Immunology Testing, Genetic Testing, Toxicology Testing, Neurology Testing, and Others
4.2.2: Market by Technology: Chemiluminescence Immunoassay (CLIA), Enzyme-linked Immunosorbent Assay (ELISA), Mass Spectrometry, Real Time – PCR, Flow Cytometry, Radioimmunoassay, and Others
4.2.3: Market by End User: Independent and Reference Laboratories and Hospital Laboratories
4.3: European Esoteric Testing Market
4.3.1: Market by Product Type: Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Immunology Testing, Genetic Testing, Toxicology Testing, Neurology Testing, and Others
4.3.2: Market by Technology: Chemiluminescence Immunoassay (CLIA), Enzyme-linked Immunosorbent Assay (ELISA), Mass Spectrometry, Real Time – PCR, Flow Cytometry, Radioimmunoassay, and Others
4.3.3: Market by End User: Independent and Reference Laboratories and Hospital Laboratories
4.4: APAC Esoteric Testing Market
4.4.1: Market by Product Type: Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Immunology Testing, Genetic Testing, Toxicology Testing, Neurology Testing, and Others
4.4.2: Market by Technology: Chemiluminescence Immunoassay (CLIA), Enzyme-linked Immunosorbent Assay (ELISA), Mass Spectrometry, Real Time – PCR, Flow Cytometry, Radioimmunoassay, and Others
4.4.3: Market by End User: Independent and Reference Laboratories and Hospital Laboratories
4.5: ROW Esoteric Testing Market
4.5.1: Market by Product Type: Infectious Diseases Testing, Endocrinology Testing, Oncology Testing, Immunology Testing, Genetic Testing, Toxicology Testing, Neurology Testing, and Others
4.5.2: Market by Technology: Chemiluminescence Immunoassay (CLIA), Enzyme-linked Immunosorbent Assay (ELISA), Mass Spectrometry, Real Time – PCR, Flow Cytometry, Radioimmunoassay, and Others
4.5.3: Market by End User: Independent and Reference Laboratories and Hospital Laboratories
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Market Share Analysis
5.3: Operational Integration
5.4: Geographical Reach
5.5: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for Global Esoteric Testing Market by Product Type
6.1.2: Growth Opportunities for Global Esoteric Testing Market by Technology
6.1.3: Growth Opportunities for Global Market by End User
6.1.4: Growth Opportunities for Global Esoteric Testing Market by Region
6.2: Emerging Trends in Global Esoteric Testing Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of Global Esoteric Testing Market
6.3.3: Mergers, Acquisitions and Joint Ventures in the Global Esoteric Testing Market
7. Company Profiles of Leading Players
7.1: Labcorp
7.2: Quest Diagnostics
7.3: Opko Health
7.4: Miraca
7.5: Myriad Genetics
7.6: Sonic Healthcare
7.7: Foundation Medicine
7.8: ACM Global Laboratories